Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
1.
Rev Esp Cardiol (Engl Ed) ; 75(4): 308-315, 2022 Apr.
Artículo en Inglés, Español | MEDLINE | ID: mdl-33994338

RESUMEN

INTRODUCTION AND OBJECTIVES: Telomeres are noncoding regions located at the end of chromosomes and their shortening has been associated with risk factors and cardiovascular disease. The aim of this study was to evaluate the association between ideal cardiovascular health (Life's simple 7) and the odds of having short telomeres in a subsample of participants older than 55 years from the Seguimiento Universidad de Navarra (SUN) study. METHODS: We included 886 participants older than 55 years (645 men and 241 women). Telomere length was measured using a real-time quantitative polymerase chain reaction. Cardiovascular health score was defined by the American Heart Association as a composite score of 7 key risk factors (smoking status, physical activity, diet, body mass index, blood pressure, total cholesterol, and fasting blood glucose) with 0 to 2 points for each factor. We categorized this score in tertiles as poor (0-9 points), intermediate (10-11 points) and ideal (12-14 points). The odds of having short telomeres was defined as telomere length below the 20th percentile. RESULTS: Individuals with higher ideal cardiovascular health had a lower prevalence of having short telomeres (adjusted OR, 0.60; 95%CI, 0.34-1.05; P trend=.052). This association was statistically significant in men (adjusted OR, 0.37; 95%CI, 0.17-0.83; P trend=.025) but not in women. CONCLUSIONS: An inverse association between cardiovascular health score and short telomeres was found especially for men older than 55 years in the SUN population. The SUN project was registered at ClinicalTrials.gov (Identifier: NCT02669602).


Asunto(s)
Enfermedades Cardiovasculares , Ejercicio Físico , American Heart Association , Presión Sanguínea/fisiología , Índice de Masa Corporal , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/genética , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Telómero/genética , Estados Unidos
2.
Nutrients ; 13(2)2021 Jan 20.
Artículo en Inglés | MEDLINE | ID: mdl-33498461

RESUMEN

Elevated circulating plasma levels of both lipopolysaccharide-binding protein (LBP) and chemerin are reported in patients with obesity, but few studies are available on lifestyle intervention programs. We investigated the association of both LBP and chemerin plasma levels with metabolic syndrome (MetS) outcomes in a lifestyle intervention in children and adolescents with abdominal obesity Methods: Twenty-nine patients enrolled in a randomized controlled trial were selected. The lifestyle intervention with a 2-month intensive phase and a subsequent 10-month follow-up consisted of a moderate calorie-restricted diet, recommendations to increase physical activity levels, and nutritional education. Results: Weight loss was accompanied by a significant reduction in MetS prevalence (-43%; p = 0.009). Chemerin (p = 0.029) and LBP (p = 0.033) plasma levels were significantly reduced at 2 months and 12 months, respectively. At the end of intervention, MetS components were associated with both LBP (p = 0.017) and chemerin (p < 0.001) plasma levels. Conclusions: We describe for the first time a reduction in both LBP and chemerin plasma levels and its association with MetS risk factors after a lifestyle intervention program in children and adolescents with abdominal obesity. Therefore, LBP and chemerin plasma levels could be used as biomarkers for the progression of cardiovascular risk in pediatric populations.


Asunto(s)
Restricción Calórica , Proteínas Portadoras/sangre , Quimiocinas/sangre , Estilo de Vida , Glicoproteínas de Membrana/sangre , Síndrome Metabólico/metabolismo , Obesidad Abdominal/metabolismo , Proteínas de Fase Aguda , Adolescente , Factores de Riesgo Cardiometabólico , Niño , Ejercicio Físico , Femenino , Humanos , Masculino , Obesidad Abdominal/dietoterapia , Pérdida de Peso
3.
Appl Physiol Nutr Metab ; 46(3): 205-212, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-32871095

RESUMEN

The purpose of this study was to assess the effect of physical activity (PA) changes, measured by accelerometry, on telomere length (TL) in pediatric patients with abdominal obesity after a lifestyle intervention. One hundred and twenty-one children (7-16 years old) with abdominal obesity were randomized to the intervention (a moderately hypocaloric Mediterranean diet) or the usual care group (standard pediatric recommendations) for 22 months (a 2 month intensive phase and a subsequent 20 month follow-up). Both groups were encouraged to accumulate an extra 200 min/week of PA. TL was measured by MMqPCR. Data were analyzed in 102 subjects after 2 months and 64 subjects at the first 10 months of follow-up. Light PA level decreased in both groups after 12 months of intervention. At month 2, moderate to vigorous PA (MVPA) increased in the intervention group (+5.4 min/day, p = 0.035) and so did sedentary time in the usual care group (+49.7 min/day, p = 0.010). TL changes were positively associated (p < 0.050) with metabolic equivalents (METs), MVPA level, and number of steps, and were inversely associated with sedentary and light PA levels in the intervention group after the intensive phase. In conclusion, favourable changes in PA levels in the intensive phase of a lifestyle intervention could contribute to TL maintenance in a pediatric population with abdominal obesity. Novelty Changes in physical activity levels had a direct effect on telomere length, a biomarker of cellular aging and oxidative stress. PA advice based on The American College of Sports Medicine included in this intervention is easy to implement in primary care.


Asunto(s)
Ejercicio Físico , Estilo de Vida , Obesidad Abdominal/terapia , Obesidad Infantil/terapia , Telómero/ultraestructura , Acelerometría , Adolescente , Niño , Dieta Mediterránea , Femenino , Humanos , Masculino , Conducta Sedentaria , España
4.
Clin Nutr ; 39(8): 2487-2494, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-31767135

RESUMEN

BACKGROUND: Shorter telomeres are associated with several age-related diseases, and lifestyle factors could influence this relationship. The aim of this study was to examine associations between salivary telomere length (TL) and diet quality using 5 evidence-based dietary indexes in an elderly (>55 years old) Spanish population of the SUN project (n = 886). METHOD: TL was measured using the quantitative real-time polymerase chain reaction. Age-adjusted TL variable through residuals methods was used for all analysis. Diet quality was assessed by the Prime Diet Quality Score (PDQS), Fat Quality Index (FQI), Mediterranean Diet Adherence Screener (MEDAS), Dietary Approaches to Stop Hypertension (DASH) index and the Alternative Healthy Eating Index (AHEI-2010). RESULTS: TL did differ according to sex, smoking status, and dyslipidemia in elderly subjects of the SUN study. In addition, subjects with dyslipidemia (compared to absence of dyslipidemia) had a significantly higher risk (27% vs. 18%, p = 0.015) of short telomeres (

Asunto(s)
Dieta Saludable/estadística & datos numéricos , Ingestión de Alimentos/genética , Saliva/química , Acortamiento del Telómero/genética , Telómero/metabolismo , Anciano , Encuestas sobre Dietas , Femenino , Evaluación Geriátrica , Humanos , Masculino , Persona de Mediana Edad , Reacción en Cadena en Tiempo Real de la Polimerasa , Medición de Riesgo , Factores de Riesgo , Encuestas y Cuestionarios
5.
Nutrients ; 11(5)2019 Apr 26.
Artículo en Inglés | MEDLINE | ID: mdl-31035493

RESUMEN

Mutations leading to a reduced function of the melanocortin-4 receptor (MC4R) exert a major gene effect on extreme obesity. Recently it was shown that the bone derived hormone lipocalin 2 (LCN2) binds to the MC4R and activates a MC4R dependent anorexigenic pathway. We identified mutations in both genes and screened the effects of MC4R and LCN2 mutations on eating behavior and weight change after a lifestyle intervention. One hundred and twelve children (11.24 ± 2.6 years, BMI-SDS 2.91 ± 1.07) with abdominal obesity participated in a lifestyle intervention. MC4R and LCN2 coding regions were screened by Sanger sequencing. Eating behavior was assessed at baseline with the Children Eating Behavior Questionnaire (CEBQ). We detected three previously described non-synonymous MC4R variants (Glu42Lys, Thr150Ile, and Arg305Gln) and one non-synonymous polymorphism (Ile251Leu). Regarding LCN2, one known non-synonymous variant (Thr124Met) was detected. Eating behavior was described in carriers of the MC4R and LCN2 mutation and in non-carriers. MC4R and LCN2 mutations were detected in 2.42% and 0.84%, respectively, of Spanish children with abdominal obesity. A number of subjects with functional mutation variants in MC4R and LCN2 were able to achieve a reduction in BMI-SDS after a lifestyle intervention.


Asunto(s)
Variación Genética , Lipocalina 2/genética , Obesidad Abdominal/genética , Obesidad Infantil/genética , Receptor de Melanocortina Tipo 4/genética , Adolescente , Índice de Masa Corporal , Niño , Conducta Alimentaria , Femenino , Humanos , Estilo de Vida , Masculino , España
6.
Nutr Hosp ; 35(2): 279-285, 2018 03 01.
Artículo en Inglés | MEDLINE | ID: mdl-29756959

RESUMEN

BACKGROUND: serotonin signaling participates in body weight regulation and glucose metabolism. However, little information is available on circulating serotonin levels in obese subjects after a weight loss program. We aimed to assess the effect of a lifestyle intervention on serotonin levels in obese children and possible associations with anthropometric and blood glucose measurements. METHODS: forty-four obese children were enrolled in a ten-week lifestyle intervention consisting of a moderate caloric restriction diet, nutritional education and familial involvement. They were distributed according to the weight loss response. Subjects who lost > 0.5 BMI-SDS were considered as high responders (HR; n = 22) and those who lost ≤ 0.5 BMI-SDS, as low responders (LR; n = 22). Anthropometric, biochemical parameters and plasma serotonin levels were measured as pre and post-intervention values. RESULTS: obese children (HR and LR groups) were able to reduce anthropometric indices and to improve glucose profile after the intervention. Interestingly, plasma serotonin levels were significantly (p ˂0.05) reduced in all subjects (-35.14 nmol/l HR group and -30.63 nmol/l LR group). Moreover, multiple-adjusted regression models showed a significant association between pre-intervention (R2 = 0.224, B = 0.047; p = 0.004) and post-intervention (R2 = 0.140; B = 0.055; p = 0.042) plasma serotonin and glucose levels. In addition, in HR subjects changes in plasma serotonin were associated with changes in glucose levels (R2 = 0.292; b = 0.04; p = 0.045). Interestingly, pre and post-intervention plasma serotonin levels were inversely associated (p ˂0.05) with anthropometric measures. CONCLUSIONS: serotonin levels were reduced after a lifestyle intervention independently of the program response. Moreover, plasma serotonin levels were associated with glucose and anthropometric measures in obese children.


Asunto(s)
Glucemia/metabolismo , Obesidad Infantil/sangre , Obesidad Infantil/terapia , Serotonina/sangre , Adolescente , Antropometría , Niño , Dieta Reductora , Femenino , Humanos , Estilo de Vida , Masculino , Educación del Paciente como Asunto , Obesidad Infantil/dietoterapia , Pérdida de Peso
7.
Nutrients ; 10(1)2017 Dec 23.
Artículo en Inglés | MEDLINE | ID: mdl-29295516

RESUMEN

DNA methylation could be reversible and mouldable by environmental factors, such as dietary exposures. The objective was to analyse whether an intervention with two Mediterranean diets, one rich in extra-virgin olive oil (MedDiet + EVOO) and the other one in nuts (MedDiet + nuts), was influencing the methylation status of peripheral white blood cells (PWBCs) genes. A subset of 36 representative individuals were selected within the PREvención con DIeta MEDiterránea (PREDIMED-Navarra) trial, with three intervention groups in high cardiovascular risk volunteers: MedDiet + EVOO, MedDiet + nuts, and a low-fat control group. Methylation was assessed at baseline and at five-year follow-up. Ingenuity pathway analysis showed routes with differentially methylated CpG sites (CpGs) related to intermediate metabolism, diabetes, inflammation, and signal transduction. Two CpGs were specifically selected: cg01081346-CPT1B/CHKB-CPT1B and cg17071192-GNAS/GNASAS, being associated with intermediate metabolism. Furthermore, cg01081346 was associated with PUFAs intake, showing a role for specific fatty acids on epigenetic modulation. Specific components of MedDiet, particularly nuts and EVOO, were able to induce methylation changes in several PWBCs genes. These changes may have potential benefits in health; especially those changes in genes related to intermediate metabolism, diabetes, inflammation and signal transduction, which may contribute to explain the role of MedDiet and fat quality on health outcomes.


Asunto(s)
Enfermedades Cardiovasculares/prevención & control , Metilación de ADN , Dieta Saludable , Dieta Mediterránea , Metabolismo Energético/genética , Epigénesis Genética , Leucocitos/metabolismo , Nueces , Aceite de Oliva , Anciano , Anciano de 80 o más Años , Enfermedades Cardiovasculares/sangre , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/genética , Comorbilidad , Islas de CpG , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores Protectores , Factores de Riesgo , España/epidemiología , Factores de Tiempo , Resultado del Tratamiento
8.
Endocrinol Diabetes Nutr ; 64 Suppl 1: 15-22, 2017 Mar.
Artículo en Inglés, Español | MEDLINE | ID: mdl-27543006
9.
Clin Nutr ; 36(1): 209-217, 2017 02.
Artículo en Inglés | MEDLINE | ID: mdl-26614254

RESUMEN

BACKGROUND & AIMS: In vivo and in vitro evidence suggests that antioxidant vitamins and carotenoids may be key factors in the treatment and prevention of obesity and obesity-associated disorders. Hence, the objective of the present study was to determine the relationship between plasma lipid-soluble antioxidant vitamin and carotenoid levels and adiposity and cardio-metabolic risk markers in overweight and obese adolescents participating in a multidisciplinary weight loss programme. METHODS: A therapeutic programme was conducted with 103 adolescents aged 12-17 years old and diagnosed with overweight or obesity. Plasma concentrations of α-tocopherol, retinol, ß-carotene and lycopene, anthropometric indicators of general and central adiposity, blood pressure and biochemical parameters were analysed at baseline and at 2 and 6 months of treatment. RESULTS: Lipid-corrected retinol (P < 0.05), ß-carotene (P = 0.001) and α-tocopherol (P < 0.001) plasma levels increased significantly, whereas lipid-corrected lycopene levels remained unaltered during the treatment. Anthropometric indicators of adiposity (P < 0.001), blood pressure (P < 0.01) and biochemical parameters (P < 0.05) decreased significantly, whereas fat free mass increased significantly (P < 0.001). These clinical and biochemical improvements were related to changes in plasma lipid-corrected antioxidant vitamin and carotenoid levels. The adolescents who experienced the greatest weight loss also showed the largest decrease in anthropometric indicators of adiposity and biochemical parameters and the highest increase in fat free mass. Weight loss in these adolescents was related to an increase in plasma levels of lipid-corrected α-tocopherol (P = 0.001), ß-carotene (P = 0.034) and lycopene (P = 0.019). CONCLUSIONS: Plasma lipid-soluble antioxidant vitamin and carotenoid levels are associated with reduced adiposity, greater weight loss and an improved cardio-metabolic profile in overweight and obese adolescents.


Asunto(s)
Adiposidad , Antioxidantes/análisis , Enfermedades Cardiovasculares/sangre , Síndrome Metabólico/sangre , Obesidad Infantil/sangre , Vitaminas/sangre , Adolescente , Antropometría , Apolipoproteínas/sangre , Enfermedades Cardiovasculares/prevención & control , Carotenoides/sangre , Niño , Colesterol/sangre , Estudios de Cohortes , Dieta , Femenino , Estudios de Seguimiento , Humanos , Licopeno , Masculino , Síndrome Metabólico/prevención & control , Evaluación Nutricional , Sobrepeso/sangre , Obesidad Infantil/diagnóstico , Obesidad Infantil/terapia , Factores de Riesgo , Triglicéridos/sangre , Vitamina A/sangre , alfa-Tocoferol/sangre , beta Caroteno/sangre
10.
Mol Nutr Food Res ; 60(12): 2654-2664, 2016 12.
Artículo en Inglés | MEDLINE | ID: mdl-27600061

RESUMEN

SCOPE: This study assessed plasmatic antioxidant capabilities and xanthine oxidase (XOX) activity in metabolic syndrome patients after 5 years intervention with Mediterranean diet (MeDiet) supplemented with extra-virgin olive oil or with nuts or with low-fat diet (the PREDIMED [PREvención con Dieta MEDiterránea] study). METHODS AND RESULTS: Seventy-five participants were randomly selected. Daily energy and nutrient intake were assessed with a validated 137-item food frequency questionnaire, and adherence to the MeDiet was assessed using a 14-item questionnaire. Catalase, superoxide dismutase (SOD), myeloperoxidase, XOX activities and protein levels, and protein carbonyl derivatives, nitrotyrosine, nitrite and nitrate levels were determined in overnight fasting venous blood samples. The plasma activity and protein levels of SOD and catalase were significantly higher and XOX activity was lower in MeDiet supplemented with extra-virgin olive oil and MeDiet supplemented with nuts than in the control group. Participants in both MeDiet groups showed higher plasma nitrate levels than in the control group. Adherence to the MeDiet showed a positive correlation with SOD and catalase plasma antioxidant activities. CONCLUSION: A MeDiet enriched with either virgin olive oil or nuts enhances the plasma antioxidant capabilities and decreases XOX activity in patients with the metabolic syndrome but we did not observe changes in myeloperoxidase or markers of oxidative damage.


Asunto(s)
Dieta Mediterránea , Síndrome Metabólico/sangre , Síndrome Metabólico/dietoterapia , Nueces , Aceite de Oliva/administración & dosificación , Xantina Oxidasa/sangre , Anciano , Anciano de 80 o más Años , Biomarcadores/sangre , Catalasa/sangre , Colesterol/sangre , Dieta con Restricción de Grasas , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Evaluación Nutricional , Cooperación del Paciente , Peroxidasa/sangre , Superóxido Dismutasa/sangre , Encuestas y Cuestionarios , Tirosina/análogos & derivados , Tirosina/sangre , Xantina Oxidasa/antagonistas & inhibidores
11.
Clin Nutr ; 34(4): 694-9, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25131600

RESUMEN

BACKGROUND & AIMS: Oxidative stress and inflammation seem to be potential underlying mechanisms for telomere attrition. A lack of specific antioxidants is believed to increase free radical damage and a greater risk for telomere shortening. Our aim was to evaluate the relationship between diet and leukocyte telomere length in a cross-sectional study of children and adolescents. We hypothesized that dietary total antioxidant capacity would be positively associated with telomere length. METHODS: Telomere length was measured by quantitative real-time polymerase chain reaction in 287 participants (55% males, 6-18 years), who were randomly selected from the GENOI study. RESULTS: A positive correlation between dietary total antioxidant capacity and telomere length (r = 0.157, p = 0.007) was found after adjustment for age and energy intake. However, higher white bread consumption was associated with shorter telomeres (ß = -0.204, p = 0.002) in fully-adjusted models. Interestingly, those individuals who had simultaneously higher dietary total antioxidant capacity and lower white bread consumption significantly presented the longest telomeres. Moreover, the multivariable-adjusted odds ratio for very short telomeres was 0.30 for dietary total antioxidant capacity (p = 0.023) and 1.37 for white bread (p = 0.025). CONCLUSION: It was concluded that longer telomeres were associated with higher dietary total antioxidant capacity and lower white bread consumption in Spanish children and adolescents. These findings might open a new line of investigation about the potential role of an antioxidant diet in maintaining telomere length.


Asunto(s)
Antioxidantes/administración & dosificación , Conducta Alimentaria , Leucocitos/efectos de los fármacos , Homeostasis del Telómero/efectos de los fármacos , Adolescente , Pan , Niño , Estudios Transversales , Dieta , Carbohidratos de la Dieta/administración & dosificación , Grasas de la Dieta/administración & dosificación , Proteínas en la Dieta/administración & dosificación , Grano Comestible , Ingestión de Energía , Femenino , Genómica , Humanos , Leucocitos/química , Masculino , Evaluación Nutricional , España , Encuestas y Cuestionarios , Telómero/efectos de los fármacos , Telómero/metabolismo , Acortamiento del Telómero
12.
Nutr Hosp ; 28(5): 1515-22, 2013.
Artículo en Español | MEDLINE | ID: mdl-24160209

RESUMEN

INTRODUCTION: The high prevalence of obesity among Spanish children and adolescents has become an important public health problem. OBJECTIVE: To assess the association between dietary macronutrient intake and obesity in a case-control study of children and adolescents (aged 5.5 to 18.8) from Navarra. METHODS: Cases were 178 obese children (body mass index > 97th percentile), from Navarra. Controls were individually matched by sex and age. Anthropometric data were collected by trained personal using standardized procedures. Personal interviews were performed to collect previously validated semiquantitative food frequency questionnaires (FFQs). From these FFQs we calculated the intake of macronutrients (carbohydrates, proteins and fats) and types of fatty acids. Energy-adjusted macronutrient intake was divided into quintiles. Conditional logistic regression was used and confounder factors were taken into account. RESULTS: The macronutrient composition of the diet was similar between cases and controls, except for polyunsaturated fatty acids (PUFA) intake, which was significantly inversely associated with obesity (p for trend < 0.01), with adjusted odds ratio = 0.34 (95% CI: 0.15 to 0.77) for the fifth versus the first quintile. CONCLUSIONS: An inverse and significant association between PUFA intake and obesity was found in this case-control study.


Introducción: La alta de prevalencia de obesidad infantil en España y sus posibles consecuencias hacen de esta enfermedad un problema prioritario de salud pública. Objetivo: Valorar, mediante un estudio epidemiológico analítico de casos y controles, la asociación entre la composición en macronutrientes de la dieta y la obesidad en una muestra de niños y adolescentes navarros de 5,5 a 18,8 años. Método: Se reclutaron 178 casos, niños y adolescentes obesos (índice de masa corporal > percentil 97) en Navarra. Los controles fueron emparejados individualmente según edad y sexo. Las medidas antropométricas fueron tomadas por personal entrenado utilizando métodos estandarizados. Se realizaron entrevistas individuales para recoger información sobre la frecuencia de consumo de alimentos mediante un cuestionario previamente validado a partir del que se calculó la ingesta de macronutrientes (hidratos de carbono, proteínas y grasas) y de los subtipos de grasas. Estos resultados se dividieron en quintiles de macronutrientes ajustados por ingesta energética total. Se realizó una regresión logística condicional para estimar odds ratios ajustadas de obesidad para cada uno de los cuatro quintiles superiores de consumo, usando el quintil inferior como referencia. Resultados: La composición de macronutrientes de la dieta era similar en casos y controles, excepto para las grasas poliinsaturadas, que se asociaron inversamente a la obesidad (p tendencia lineal < 0,01) con una odds ratio ajustada de 0,34 (IC 95%: 0,15 a 0,77) para el quinto quintil. Conclusiones: Nuestros resultados sugieren una asociación inversa entre una mayor ingesta de grasas poliinsaturadas y el riesgo de obesidad.


Asunto(s)
Dieta , Ingestión de Alimentos , Alimentos , Obesidad/epidemiología , Adolescente , Estudios de Casos y Controles , Niño , Preescolar , Femenino , Humanos , Masculino
13.
J Pediatr ; 161(3): 466-470.e2, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22608907

RESUMEN

OBJECTIVE: To estimate the contribution of 9 obesity-related polymorphisms and a genetic predisposition score (GPS) on anthropometric and biochemical variables before and after a weight loss intervention program in overweight/obese Spanish adolescents. STUDY DESIGN: Overweight/obese adolescents (n = 168; 12-16 years) participating in the EVASYON program were genotyped for 9 obesity-related single nucleotide polymorphisms in the FTO, MC4R, TMEM18, IL6, PPARG, and ADIPQ genes. RESULTS: At baseline, the GPS showed a significant association with body mass index-standard deviation score (BMI-SDS) and fat mass. After 3 months of intervention, this GPS also showed a relationship with the variation of both anthropometric measurements. After adjusting for baseline BMI-SDS, subjects with a lower GPS had a greater improvement on metabolic profile, as well as a better response to physical activity, compared with those subjects with a higher GPS. CONCLUSIONS: The GPS seems to have an important relationship with BMI-SDS and fat mass both at baseline and after a 3-month weight loss lifestyle intervention. Obese and overweight adolescents with a lower GPS have a greater benefit of weight loss after 3 months of a multidisciplinary lifestyle intervention.


Asunto(s)
Índice de Masa Corporal , Sitios Genéticos/genética , Predisposición Genética a la Enfermedad , Obesidad/genética , Polimorfismo de Nucleótido Simple , Pérdida de Peso/genética , Adiponectina/genética , Adolescente , Femenino , Frecuencia de los Genes , Humanos , Interleucina-6/genética , Estilo de Vida , Masculino , Proteínas de la Membrana/genética , PPAR gamma/genética , Receptor de Melanocortina Tipo 4/genética , España
14.
PLoS One ; 7(12): e52344, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23284998

RESUMEN

BACKGROUND: Fat mass and obesity (FTO) and melanocortin-4 receptor (MC4R) and are relevant genes associated with obesity. This could be through food intake, but results are contradictory. Modulation by diet or other lifestyle factors is also not well understood. OBJECTIVE: To investigate whether MC4R and FTO associations with body-weight are modulated by diet and physical activity (PA), and to study their association with alcohol and food intake. METHODS: Adherence to Mediterranean diet (AdMedDiet) and physical activity (PA) were assessed by validated questionnaires in 7,052 high cardiovascular risk subjects. MC4R rs17782313 and FTO rs9939609 were determined. Independent and joint associations (aggregate genetic score) as well as statistical and biological gene-lifestyle interactions were analyzed. RESULTS: FTO rs9939609 was associated with higher body mass index (BMI), waist circumference (WC) and obesity (P<0.05 for all). A similar, but not significant trend was found for MC4R rs17782313. Their additive effects (aggregate score) were significant and we observed a 7% per-allele increase of being obese (OR=1.07; 95%CI 1.01-1.13). We found relevant statistical interactions (P<0.05) with PA. So, in active individuals, the associations with higher BMI, WC or obesity were not detected. A biological (non-statistical) interaction between AdMedDiet and rs9939609 and the aggregate score was found. Greater AdMedDiet in individuals carrying 4 or 3-risk alleles counterbalanced their genetic predisposition, exhibiting similar BMI (P=0.502) than individuals with no risk alleles and lower AdMedDiet. They also had lower BMI (P=0.021) than their counterparts with low AdMedDiet. We did not find any consistent association with energy or macronutrients, but found a novel association between these polymorphisms and lower alcohol consumption in variant-allele carriers (B+/-SE: -0.57+/-0.16 g/d per-score-allele; P=0.001). CONCLUSION: Statistical and biological interactions with PA and diet modulate the effects of FTO and MC4R polymorphisms on obesity. The novel association with alcohol consumption seems independent of their effects on BMI.


Asunto(s)
Consumo de Bebidas Alcohólicas/genética , Estilo de Vida , Obesidad/genética , Proteínas/genética , Receptor de Melanocortina Tipo 4/genética , Anciano , Anciano de 80 o más Años , Dioxigenasa FTO Dependiente de Alfa-Cetoglutarato , Índice de Masa Corporal , Femenino , Humanos , Masculino , Persona de Mediana Edad
15.
J Nutr Biochem ; 23(3): 218-27, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21497077

RESUMEN

Eicosapentaenoic acid (EPA) is an omega-3 polyunsaturated fatty acid with beneficial effects in obesity and insulin resistance. High levels of proinflammatory cytokine tumour necrosis factor-α (TNF-α) in obesity promote lipolysis in adipocytes, leading to the development of insulin resistance. Thus, the aims of the present study were to analyze the potential antilipolytic properties of EPA on cytokine-induced lipolysis and to investigate the possible mechanisms involved. The EPA effects on basal and TNF-α-induced lipolysis were determined in both primary rat and 3T3-L1 adipocytes. Treatment of primary rat adipocytes with EPA (100 and 200 µM) significantly decreased basal glycerol release (P<.01) and prevented cytokine-induced lipolysis in a dose-dependent manner (P<.001). Moreover, EPA decreased TNF-α-induced activation of nuclear factor-κB and extracellular-related kinase 1/2 phosphorylation. In addition, the antilipolytic action of EPA was stimulated by the AMP-kinase (AMPK) activator 5-aminoimidazole-4-carboxamide-1-b-d-ribofuranoside and blocked by the AMPK-inhibitor compound C. Moreover, we found that EPA stimulated hormone-sensitive lipase (HSL) phosphorylation on serine-565, which further supports the involvement of AMPK in EPA's antilipolytic actions. Eicosapentaenoic acid treatment (24 h), alone and in the presence of TNF-α, also decreased adipose triglyceride lipase (ATGL) protein content in cultured adipocytes. However, oral supplementation with EPA for 35 days was able to partially reverse the down-regulation of HSL and ATGL messenger RNA observed in retroperitoneal adipose tissue of high-fat-diet-fed rats. These findings suggest that EPA inhibits proinflammatory cytokine-induced lipolysis in adipocytes. This effect might contribute to explain the insulin-sensitizing properties of EPA.


Asunto(s)
Adipocitos/efectos de los fármacos , Ácido Eicosapentaenoico/farmacología , Lipólisis , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Factor de Necrosis Tumoral alfa/metabolismo , Células 3T3-L1 , Adenilato Quinasa/metabolismo , Adipocitos/citología , Adipocitos/metabolismo , Administración Oral , Animales , Dieta Alta en Grasa , Regulación hacia Abajo , Insulina/metabolismo , Grasa Intraabdominal/metabolismo , Lipasa/metabolismo , Masculino , Ratones , FN-kappa B/metabolismo , Fosforilación , Ratas , Ratas Wistar , Esterol Esterasa/genética , Esterol Esterasa/metabolismo , Factor de Necrosis Tumoral alfa/genética
16.
Int J Food Sci Nutr ; 61(7): 713-21, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20528580

RESUMEN

BACKGROUND: Dietary antioxidant intake has been suggested to protect against oxidative damage and related clinical complications. The aim of the present study was to assess the potential relationships between the dietary total antioxidant capacity (TAC) and obesity-related features in children and adolescents. MATERIALS AND METHODS: Anthropometric variables from 369 children and adolescents were measured (184 obese and 185 control). A validated food-frequency questionnaire was used to calculate the TAC and the daily nutrient and energy intake. RESULTS: Dietary TAC showed positive associations with fiber, folic acid, magnesium, and vitamins A, C and E. The body mass index, standard deviation score of body mass index and total body fat were inversely associated with dietary TAC only in obese subjects. CONCLUSION: These data suggest that dietary TAC may be a potential indicator of the risk to develop obesity-related features and could be considered a useful method in assessing antioxidant intake.


Asunto(s)
Antioxidantes/administración & dosificación , Dieta , Fibras de la Dieta/administración & dosificación , Micronutrientes/administración & dosificación , Obesidad , Tejido Adiposo , Adolescente , Biomarcadores/sangre , Índice de Masa Corporal , Niño , Encuestas sobre Dietas , Femenino , Humanos , Masculino , Obesidad/sangre , Obesidad/etiología , Estrés Oxidativo , Factores de Riesgo , Encuestas y Cuestionarios
17.
Mol Nutr Food Res ; 54 Suppl 1: S75-82, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-20352618

RESUMEN

Only a few studies have analyzed the effects of the potential interaction between the -174G/C polymorphism of IL6 gene and the adherence to the Mediterranean diet (MD) on adiposity indexes. Our aim was to investigate the interplay between the -174G/C polymorphism of the IL6 gene and a Mediterranean-style diet on body weight changes after 3 years of nutritional intervention in a high cardiovascular risk population. A total of 737 participants, aged 55-80 years were assigned to a low-fat diet or to a Mediterranean-style diet group with high intake of virgin olive oil (VOO) or nuts. Anthropometric measurements were taken at baseline and after 3-year follow-up. The -174G/C polymorphism of the IL6 gene was genotyped. Minor allele frequency (C) was 0.39. At baseline, the CC genotype was associated with higher measures of adiposity. After 3 years, a significant interaction (p=0.028) was found between the polymorphism (GG+GC versus CC) and the nutritional intervention: CC subjects following the MD+VOO had the lowest body weight gain. In conclusion, at baseline, CC subjects for the -174G/C polymorphism of IL6 had the highest body weight and BMI. However, after 3 years of nutritional intervention with MD+VOO, these subjects were predicted to have the greatest reduction in body weight.


Asunto(s)
Dieta Mediterránea , Variación Genética , Interleucina-6/genética , Aceites de Plantas/farmacología , Polimorfismo de Nucleótido Simple , Anciano , Presión Sanguínea , Índice de Masa Corporal , Peso Corporal/efectos de los fármacos , Enfermedades Cardiovasculares/epidemiología , ADN/sangre , ADN/genética , ADN/aislamiento & purificación , Diabetes Mellitus/genética , Femenino , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Nueces , Aceite de Oliva , Factores de Riesgo
18.
FASEB J ; 24(7): 2546-57, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20179144

RESUMEN

The aim of the study was to assess whether benefits associated with the traditional Mediterranean diet (TMD) and virgin olive oil (VOO) consumption could be mediated through changes in the expression of atherosclerosis-related genes. A randomized, parallel, controlled clinical trial in healthy volunteers (n=90) aged 20 to 50 yr was performed. Three-month intervention groups were as follows: 1) TMD with VOO (TMD+VOO), 2) TMD with washed virgin olive oil (TMD+WOO), and 3) control with participants' habitual diet. WOO was similar to VOO, but with a lower polyphenol content (55 vs. 328 mg/kg, respectively). TMD consumption decreased plasma oxidative and inflammatory status and the gene expression related with both inflammation [INF-gamma (INFgamma), Rho GTPase-activating protein15 (ARHGAP15), and interleukin-7 receptor (IL7R)] and oxidative stress [adrenergic beta(2)-receptor (ADRB2) and polymerase (DNA-directed) kappa (POLK)] in peripheral blood mononuclear cells. All effects, with the exception of the decrease in POLK expression, were particularly observed when VOO, rich in polyphenols, was present in the TMD dietary pattern. Our results indicate a significant role of olive oil polyphenols in the down-regulation of proatherogenic genes in the context of a TMD. In addition, the benefits associated with a TMD and olive oil polyphenol consumption on cardiovascular risk can be mediated through nutrigenomic effects.


Asunto(s)
Dieta Mediterránea , Flavonoides/metabolismo , Nutrigenómica/métodos , Fenoles/metabolismo , Aceites de Plantas/metabolismo , Adulto , Aterosclerosis/genética , Enfermedades Cardiovasculares/prevención & control , Regulación hacia Abajo/genética , Flavonoides/uso terapéutico , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Inflamación/sangre , Persona de Mediana Edad , Aceite de Oliva , Oxidación-Reducción , Fenoles/uso terapéutico , Aceites de Plantas/administración & dosificación , Aceites de Plantas/uso terapéutico , Polifenoles , Adulto Joven
19.
Br J Nutr ; 102(5): 672-9, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19267951

RESUMEN

The PPARgamma gene regulates insulin sensitivity and adipogenesis. The Pro12Ala polymorphism of this gene has been related to fat accumulation. Our aim was to analyse the effects of a 2-year nutritional intervention with Mediterranean-style diets on adiposity in high-cardiovascular risk patients depending on the Pro12Ala polymorphism of the PPARgamma gene. The population consisted of a substudy (774 high-risk subjects aged 55-80 years) of the Prevención con Dieta Mediterránea (PREDIMED) randomised trial aimed at assessing the effect of the Mediterranean diet for CVD prevention. There were three nutritional intervention groups: two of them of a Mediterranean-style diet and the third was a control group advised to follow a conventional low-fat diet. All the participants were genotyped by PCR-restriction fragment length polymorphism (RFLP). The results showed that carriers of the 12Ala allele allocated to the control group had a statistically significant higher change in waist circumference (adjusted difference coefficient = 2.37 cm; P = 0.014) compared with wild-type subjects after 2 years of nutritional intervention. This adverse effect was not observed among 12Ala carriers allocated to both Mediterranean diet groups. In diabetic patients a statistically significant interaction between Mediterranean diet and the 12Ala allele regarding waist circumference change was observed ( - 5.85 cm; P = 0.003). In conclusion, the Mediterranean diet seems to be able to reduce waist circumference in a high-cardiovascular risk population, reversing the negative effect that the 12Ala allele carriers of the PPARgamma gene appeared to have. The beneficial effect of this dietary pattern seems to be higher among type 2 diabetic subjects.


Asunto(s)
Enfermedades Cardiovasculares/epidemiología , Dieta Mediterránea , PPAR gamma/genética , Circunferencia de la Cintura/efectos de los fármacos , Anciano , Sustitución de Aminoácidos , Índice de Masa Corporal , Peso Corporal , Enfermedades Cardiovasculares/genética , Enfermedades Cardiovasculares/prevención & control , ADN/sangre , ADN/genética , Femenino , Estudios de Seguimiento , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Polimorfismo de Longitud del Fragmento de Restricción , Factores de Riesgo , Fumar/epidemiología
20.
Clin Sci (Lond) ; 117(6): 243-9, 2009 Aug 14.
Artículo en Inglés | MEDLINE | ID: mdl-19296827

RESUMEN

Visfatin is an adipokine highly expressed in visceral AT (adipose tissue) of humans and rodents, the production of which seems to be dysregulated in excessive fat accumulation and conditions of insulin resistance. EPA (eicosapentaenoic acid), an n-3 PUFA (polyunsaturated fatty acid), has been demonstrated to exert beneficial effects in obesity and insulin resistance conditions, which have been further linked to its reported ability to modulate adipokine production by adipocytes. TNF-alpha (tumour necrosis factor-alpha) is a pro-inflammatory cytokine whose production is increased in obesity and is involved in the development of insulin resistance. Control of adipokine production by some insulin-sensitizing compounds has been associated with the stimulation of AMPK (AMP-activated protein kinase). The aim of the present study was to examine in vitro the effects of EPA on visfatin production and the potential involvement of AMPK both in the absence or presence of TNF-alpha. Treatment with the pro-inflammatory cytokine TNF-alpha (1 ng/ml) did not modify visfatin gene expression and protein secretion in primary cultured rat adipocytes. However, treatment of these primary adipocytes with EPA (200 mumol/l) for 24 h significantly increased visfatin secretion (P<0.001) and mRNA gene expression (P<0.05). Moreover, the stimulatory effect of EPA on visfatin secretion was prevented by treatment with the AMPK inhibitor Compound C, but not with the PI3K (phosphoinositide 3-kinase) inhibitor LY294002. Similar results were observed in 3T3-L1 adipocytes. Moreover, EPA strongly stimulated AMPK phosphorylation alone or in combination with TNF-alpha in 3T3-L1 adipocytes and pre-adipocytes. The results of the present study suggest that the stimulatory action of EPA on visfatin production involves AMPK activation in adipocytes.


Asunto(s)
Proteínas Quinasas Activadas por AMP/metabolismo , Adipocitos/efectos de los fármacos , Ácido Eicosapentaenoico/farmacología , Nicotinamida Fosforribosiltransferasa/biosíntesis , Proteínas Quinasas Activadas por AMP/antagonistas & inhibidores , Adipocitos/metabolismo , Aminoimidazol Carboxamida/análogos & derivados , Aminoimidazol Carboxamida/farmacología , Animales , Células Cultivadas , Cromonas/farmacología , Ácido Eicosapentaenoico/antagonistas & inhibidores , Activación Enzimática/efectos de los fármacos , Hipoglucemiantes/farmacología , Masculino , Ratones , Morfolinas/farmacología , Inhibidores de Proteínas Quinasas/farmacología , Pirazoles , Pirimidinas , Ratas , Ribonucleótidos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA